Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates
Published in
Molecular therapy, vol. 17, no. 10, p. 1754-1760Publication date
2009Abstract
Keywords
- Animals
- Antiviral Agents/pharmacology
- Blotting, Western
- Cell Line
- Cells, Cultured
- Erythropoietin/genetics/physiology
- Ganciclovir/analogs & derivatives/pharmacology
- Gene Therapy/methods
- Genetic Vectors/genetics
- Hela Cells
- Hepatocytes/cytology/drug effects/virology
- Humans
- Lentivirus/genetics
- Liver Diseases/therapy
- Macaca fascicularis
- Male
- Polymerase Chain Reaction
- Simplexvirus/genetics
- Thymidine Kinase/genetics/physiology
- Transduction, Genetic/methods
- Viral Proteins/genetics/physiology
UNIGE affiliation entities
- Faculté de médecine / Section de médecine fondamentale / Département de microbiologie et médecine moléculaire
- Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique
- Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences
UNIGE research groups
Citation (ISO format)
MENZEL, Olivier et al. Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates. In: Molecular therapy, 2009, vol. 17, n° 10, p. 1754–1760. doi: 10.1038/mt.2009.143
Main files (1)
Article (Published version)
Identifiers
- PID : unige:4761
- DOI : 10.1038/mt.2009.143
- PMID : 19568222
